These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy. Banerjee A; Velagaleti R; Patil S; Pawar M; Yadav P; Kadam P; Qadri MM; Chakraborti S; Saini JS; Behera DB; Karanjai K; Iyer PS; Gharat LA; Das S Bioorg Med Chem Lett; 2021 Sep; 47():128202. PubMed ID: 34139325 [TBL] [Abstract][Full Text] [Related]
9. Site selective syntheses of [(3)H]omeprazole using hydrogen isotope exchange chemistry. Pollack SR; Schenk DJ J Labelled Comp Radiopharm; 2015; 58(11-12):433-41. PubMed ID: 26380956 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease. Burrell RC; Easter JA; Cassidy MP; Gillman KW; Olson RE; Bonacorsi SJ J Labelled Comp Radiopharm; 2014 Aug; 57(10):600-5. PubMed ID: 25196195 [TBL] [Abstract][Full Text] [Related]
11. Aortic Binding of AZD5248: Mechanistic Insight and Reactivity Assays To Support Lead Optimzation. Bragg RA; Brocklehurst S; Gustafsson F; Goodman J; Hickling K; MacFaul PA; Swallow S; Tugwood J Chem Res Toxicol; 2015 Oct; 28(10):1991-9. PubMed ID: 26351880 [TBL] [Abstract][Full Text] [Related]
12. The synthesis of one H-2 labeled and two H-3 labeled leukotriene C4 synthase inhibitors. Bergare J; Kingston L; Guly DJ; Dolan J; Lewis RJ; Elmore CS J Labelled Comp Radiopharm; 2020 Aug; 63(10):434-441. PubMed ID: 32441366 [TBL] [Abstract][Full Text] [Related]
13. Review: Self-radiolysis of compounds containing tritium and carbon-14. Wolf JR J Labelled Comp Radiopharm; 2021 Jun; 64(8):286-335. PubMed ID: 33439502 [TBL] [Abstract][Full Text] [Related]
14. Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitors. Ren S; Hesk D; McNamara P; Koharski D; Hendershot S J Labelled Comp Radiopharm; 2013; 56(9-10):480-4. PubMed ID: 24285525 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and application of isocyanates radiolabeled with carbon-11. Wilson AA; Garcia A; Houle S; Sadovski O; Vasdev N Chemistry; 2011 Jan; 17(1):259-64. PubMed ID: 21207622 [TBL] [Abstract][Full Text] [Related]
16. Tritiation of nonpeptide substance P antagonist CP-96,345 and its azido analogue. Synthetic and characterization details. Egan JA; Filer CN Appl Radiat Isot; 2003; 59(5-6):333-5. PubMed ID: 14622931 [TBL] [Abstract][Full Text] [Related]
18. Dynamic Carbon Isotope Exchange of Pharmaceuticals with Labeled CO Destro G; Loreau O; Marcon E; Taran F; Cantat T; Audisio D J Am Chem Soc; 2019 Jan; 141(2):780-784. PubMed ID: 30586301 [TBL] [Abstract][Full Text] [Related]
19. [¹¹C]NS9531, [¹¹C]NS9762 and [¹¹C]NS6417, specific SERT tracers: pre-clinical evaluation in pigs and optimization of synthesis conditions using [¹¹C]methyl triflate. Dam JH; Bender D; Peters D; Någren K Nucl Med Biol; 2016 Jan; 43(1):42-51. PubMed ID: 26702786 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus serine protease: synthesis of radioactive and stable isotope-labeled potent inhibitors. Latli B; Hrapchak M; Gorys V; Llinàs-Brunet M; Campbell SS; Song J; Senanayake CH J Labelled Comp Radiopharm; 2014 May; 57(5):350-7. PubMed ID: 24700697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]